Heavy Smoking and Vision Loss

Researchers at Rutgers University Behavioral Health Care reported findings of a study in Psychiatry Research demonstrating that smoking more than 20 cigarettes a day can damage your vision. The Centers for Disease Control and Prevention estimates that 34.3 million adults in the US currently smoke cigarettes and that more than 16 million live with a smoking-related disease, many of which affect the cardiovascular system. Cigarette smoke consists of numerous neurotoxic compounds that are harmful to health. These neurotoxic chemicals are believed to result in nerve damage to the optic nerve and retinal nerve fiber layer resulting in a loss of color vision and contrast sensitivity. This damage is in addition to the known harmful effects of smoking which doubles the risk for age-related macular degeneration (AMD) and hastens the yellowing of the crystalline lens of the eye where cataracts form.

If you or someone you know is a smoker-now is the time to quit! To learn more about eye health and smoking schedule an eye exam at Center for Sight 508-730-2020, visit Center for Sight or www.facebook.com/centerforsightfallriver.

Center for Sight is conveniently located at 1565 North Main Street, Suite 406, Fall River, Massachusetts 02720 for patients from Massachusetts or Rhode Island.

Deep Learning & Macular Degeneration Risk Assessment

Age Related Macular Degeneration (AMD) is a leading cause of vision loss in seniors. Aging is the greatest risk factor! In its most advanced stages, it can deprive an individual of his or her ability to perform basic activities such as reading, recognizing faces, and driving. Approximately 11 million individuals are affected with AMD in the United States (U.S.) alone and the prevalence of AMD in the U.S. is anticipated to increase to 22 million by the year 2050.

Early detection and treatment is critical in helping patients avoid vision loss from AMD. Recently researchers reported interesting results in the journal JAMA Ophthalmology regarding how “deep learning” (DL) or artificial intelligence (AI) might be a useful addition to the physician in the examination and monitoring process for patients at risk for AMD and its progression. Their findings suggest that using DL to grade and monitor AMD is comparable to experienced humans for estimating 5-year risk of progression to advanced AMD. This could be very helpful in assisting physicians in having a detailed risk assessment in the long term care of AMD patient.

If you want to learn more about your risk of age related macular degeneration (AMD), schedule an eye exam at Center for Sight 508-730-2020, visit Center for Sight or www.facebook.com/centerforsightfallriver.

Center for Sight is conveniently located at 1565 North Main Street, Suite 406, Fall River, Massachusetts 02720 for patients from Massachusetts or Rhode Island.